Shopping Cart
Remove All
Your shopping cart is currently empty
Tositumomab
(Synonyms: V10XA53, Anti-Human CD20 Recombinant Antibody) Copy Product Info
🥰Excellent
Synonyms: V10XA53, Anti-Human CD20 Recombinant Antibody
Catalog No. T76835 Copy Product Info
Purity: 95%
🥰Excellent
Tositumomab is a murine IgG2a lambda monoclonal antibody that selectively binds to the CD20 antigen expressed on the surface of normal and malignant B lymphocytes. Tositumomab is widely utilized in research for B cell-targeted therapies, immunological studies, and the development of radioimmunoconjugates for cancer treatment.
Tositumomab
Cas No. 192391-48-3
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $645 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,460 | - | In Stock | |
| 50 mg | $1,970 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:95.1% (SDS-PAGE); 97.5% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Tositumomab is a murine IgG2a lambda monoclonal antibody that selectively binds to the CD20 antigen expressed on the surface of normal and malignant B lymphocytes. Tositumomab is widely utilized in research for B cell-targeted therapies, immunological studies, and the development of radioimmunoconjugates for cancer treatment. |
| In vitro | In the mouse xenograft model of human Raji lymphoma cells, Tositumomab (131I-tositumomab) at a dose of 2,035 kBq could inhibit tumor growth and prolong the survival period [1]. |
| In vivo | In the mouse xenograft model of human Raji lymphoma cells, Tositumomab (131I-tositumomab) at a dose of 2,035 kBq could inhibit tumor growth and prolong the survival period [1]. |
| Synonyms | V10XA53, Anti-Human CD20 Recombinant Antibody |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD20 |
| Molecular Weight | 147.25 kDa |
| Cas No. | 192391-48-3 |
| Isotype | mIgG2a |
| Storage | Store at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: Tositumomab in vivo | Tositumomab in vitro | Tositumomab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.